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Objectives: This study aimed to develop a list of potentially inappropriate drugs for the elderly in Korea using the Delphi 
technique. Methods: A Delphi evaluation with a two-round survey was used to reach a consensus on the criteria for inap-
propriate medications for the elderly in an outpatient setting. The expert panel consisted of 7 family medicine specialists, 3 
psychiatrists, 1 neurologist and 3 clinical pharmacists. The level of inappropriateness was determined by considering clinical 
importance of the risk and availability of alternative therapy, and was rated on a scale of 1 (very low) to 4 (very high). The 
drugs were categorized into three groups. The first group (Group 1) was drugs that should be avoided. The second (Group 
2) was for drugs that need to be monitored. And the third (Group 3) was for drugs with a low level of risk. Results: We took 
a list of 60 ingredients for drugs and created a list of 57 potentially inappropriate ingredients for the elderly, independent of 
diagnosis. Forty-two drugs were classified as Group 1. 13 drugs were classified as Group 2. And 2 drugs were classified as 
Group 3.  Ninety-three drugs were potentially inappropriate for the elderly with 29 diagnoses. Groups 1, 2, and 3 included 63, 
28, and 3 drugs, respectively. Conclusions: This study is an important development of a list of drugs potentially inappropriate 
for the elderly in Korea. The application of this list may be useful for identifying potentially inappropriate medication uses 
and decreasing drug-related problems.
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I. Introduction
As the elderly population grows, the prevalence of aging-
related disease and drug expenditure has increased in Korea. 
The population of age 65 or more has reached 9.6% of the to-
tal population in the year 2006, and is projected to be 14.3% 
by 2018 and 20.8% by 2026 [1]. Despite the fact that only 9.6 
% of the population is aged 65 or older, they still account for 
25% of total health expenditure, which is a relatively high 
medical cost compared to other age groups [2]. An aging 
society implies that there is a higher prevalence of chronic 
degenerative disease, which leads to more prescriptions for 
drug therapy. About 90.9% of the elderly have chronic dis-
ease, and in Korea, it has been reported that 73.8% of the 
elderly have more than two chronic diseases [3]. It has also 
been reported that 77.7% of the elderly are currently tak-
ing at least one medication [4]. This is a common problem 
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in many countries, for instance in the United States, where 
more than 80% of the elderly take more than one medication 
[5].
  Frequent exposure to medications increases the likelihood 
of developing complications from drug therapy. A high rate 
of medication use makes older adults particularly vulnerable 
to medication-related problems, combined with age-related 
physiological changes in the way drugs are absorbed, distrib-
uted, metabolized, and excreted [6]. Inappropriate medica-
tion use in elderly patients has been linked to a large share of 
adverse drug reactions [7], worsening physical functions [8], 
and excess health care utilization. Therefore, the use of inap-
propriate medications by elderly patients is an important 
concern for patient safety and for the rational use of health 
care resources. 
  Copper [9] reported that 10-35% of the elderly report 
adverse effects after medication, and that 1/3 of all hospi-
talizations of elderly patients are partly due to adverse drug 
reactions. Hanlon et al. [10] reported that 35% of outpatients 
experience drug-related side effects; 29% of those patients 
revisited medical facilities, including emergency rooms, to 
treat these side effects.
  Since the 1990s, criteria have been used to assess inap-
propriate medication use. At the beginning implicit criteria 
was developed, but which is often considered impractical to 
use in population-based studies. So the explicit criteria were 
developed by panels of experts in geriatric medicine and 
pharmacology. Two sets of explicit criteria, the Beers crite-
ria [6,11,12] and Canadian criteria [13], have been used for 
safer drug administration and preparation, clinical educa-
tion, health outcomes, and medical cost and benefits analysis 
for the last decade. Beers et al. [11] quantified the appropri-
ateness of drug prescriptions for nursing home residents, 
and added the severity noting high or low risk in 1997 [12]. 
Since then, Beers criteria were updated for the Beers criteria 
in 2002 [6]. The Beers criteria selected inappropriate drugs 
for use at outpatient and long-term care facilities for the el-
derly by an extensive literature review and a modified Delphi 
method, as evaluated by twelve geriatrics and pharmacology 
specialists. The Beers criteria categorize the drugs into two 
groups, either independent of diagnosis (ID) or considering 
diagnosis (CD), depending on the critical condition. This 
method was then selected for nursing home regulation by 
Center for Medicare & Medicaid Service (CMS) in July 1999, 
and for quality indicators for managed care plans by Health 
Plan and Employer Data and Information Set (HEDIS) 
[6,14]. Zhan’s classification consists of 33 categories of drugs, 
which are categorized as prohibited for the elderly regardless 
of dosage, frequency and duration; potentially inappropriate; 
or appropriate under certain conditions [15]. McLeod et al. 
[13] developed the Canadian criteria for inappropriate prac-
tices in prescribing for elderly people.
  Although the Beers criteria (1997, 2003) [6,12] and the 
Canadian criteria (1997) [13] were developed based on an 
extensive literature review and expert opinions, they are 
applied to drugs used for patients in long-term care such 
as nursing homes. Thus, these criteria may not be useful to 
assess medications given for a short time period in an out-
patient setting. In addition, it may not be possible to apply 
the criteria to Korean people directly, since the criteria are 
developed for drugs used in the United States only. Addi-
tionally, the expert consensus panel consisted of 6 different 
nationalities and some of the drugs in the list are not avail-
able in South Korea. Therefore, list of potentially inappropri-
ate medication for the Korean elderly need to be developed.
  The purpose of this study is to develop the list of potentially 
inappropriate drugs for the elderly in Korea using the Del-




In order to identify applicable criteria for medication use for 
elderly persons in a community setting in Korea, this study 
included several steps. First, previously published criteria for 
potentially inappropriate drugs was reviewed and matched 
with the list for reimbursable drugs in Korea. Next, a survey 
questionnaire for the expert panel was developed. Then, 
opinions from the expert panel through a Delphi evaluation 
were compared with the Beers criteria and the Canadian 
criteria, and then the level of inappropriateness was deter-
mined, taking into account adverse effects and availability of 
substitutable drugs.
2. Selection of Drugs for Which a Decision is Required 
We adopted list from Beers criteria [6,11,12], Canadian cri-
teria [13] and Zhan’s classification [15] using Fialova et al.’s 
therapeutic classification [16], and identified 17 therapeutic 
classes as potentially inappropriate drugs, regardless of the 
disease. While the Beers criteria [6] indicated barbiturates as 
a class of drugs, we specified barbiturates to include amytal 
sodium, pentobarbital, secobarbital, and thiopental. With 
regard to disease-specific potentially inappropriate drugs 
for the elderly, the disease code is provided from persons 
who are in charge of the medical records. For this category, 
β-adrenergic blocking agent, anticholinergics, antihista-
mines, antispasmodics, antidepressants, decongestants, 233 Vol. 16  •  No. 4  •  December 2010 www.e-hir.org
Medication Use Criteria in the Elderly
non steroidal anti-inflammatory drugs (NSAIDs), calcium 
channel blocker, tricyclic antidepressants (TCA), thiazide 
diuretic, steroids, conventional antipsychotics, and long ben-
zodiazepine are included.
3. Questionnaires for the Expert Panel
Adverse effects of pharmaceuticals and the drugs that can 
be substituted are presented in questionnaires for the Delphi 
evaluation. Three main questions for the expert panel mem-
bers were clinical importance of side effects, availability of 
possible substitute drugs, and conditions for which drugs 
should be used. The first two questions were answered on 
4-response Likert scales and the last question was open ended. 
  The drug-related side effects were summarized after a re-
view of Beers et al. [11,12,6], McLeod et al. [13], and Zhan 
et al. [15], and substitutable drugs were as specified by the 
WHO Collaborating Center [17], KIMS data, and MICRO-
MEDEX Healthcare Series (Figure 1). The second round 
questionnaires were consisted of evaluating appropriateness 
of indicators using potentially inappropriate drugs for the 
elderly and suggesting other opinion in the second round if 
they did not agree with results from the first round. 
4. The Expert Panel Members and Data Collection
The expert panel consisted of 14 geriatric specialists, includ-
ing 7 family medicine specialists, 3 psychiatrists, 1 neurolo-
gist and 3 clinical pharmacists. The expert panel performed 
the survey in two rounds.
  From the first round of Delphi evaluations, the drugs were 
categorized into three groups based on answers from the 
first two questions. Drugs for which more than 50% of panel 
members answered level 3 or 4 for both questions were 
classified as group 1. If less than 50% of panel members 
answered level 3 or 4 for either question, those drugs were 
identified as group 2 and the remaining drugs were identi-
fied as group 3 (Table 1). 
  In the second round, the expert panel could suggest their 
opinion if they did not agree with results from the first 
round and the utility data of drugs with group 1 were pro-
vided for reference. The categories were adjusted and final-
ized into three groups for the elderly: drugs that should be 
avoided (group 1), those that need to be monitored (group 2), 
and drugs with a low level of risk (group 3). 
III. Results
1. Potentially Inappropriate Drugs, Independent of Diag-
nosis 
The expert panel developed a list of 57 potentially inappro-
priate ingredients for the elderly, independent of diagnosis, 
among the 60 ingredients. Forty-two drugs were classified 
Table 1. The operational definition of agreement
Agree on clinical 
importance of adverse 
effects (no. of experts)
Agree on substitutable 
drug (no. of experts)
Level
8-14   8-14 1
4-7 2
0-3 2
4-7   8-14 2
4-7 3
0-3 3
0-3   8-14 3
4-7 3
0-3 3
Figure 1. Example for survey questionnaire. NSAIDs: non steroidal anti-inflammatory drugs, CNS: central nervous systems. 234 doi: 10.4258/hir.2010.16.4.231 www.e-hir.org
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into group 1 (drugs that need to be avoided), 13 drugs into 
group 2 (drugs that need to be monitored), and 2 drugs into 
group 3 (drugs with minimal harm to the elderly) (Table 2).
  Table 2 shows the list of potentially inappropriate drugs, in-
dependent of diagnosis. Among all of the drugs from drugs 
of both Beer Criteria [6] and Canadian Criteria [13], thirty 
drugs were not listed and three ingredients that are consid-
ered to be inappropriate for the elderly were excluded. The 
drugs that were excluded were antibacterial (nitrofurantoin), 
antiemetic (trimethobenzamide) and vasodilatory (cy-
clandelate). The unlisted drugs were analgesic/anti-inflam-
matory (mefenamic acid, phenylbutazone), anticholinergic 
(tripelennamine, dexchlorpheniramie, clidinum, clidinum-
chlordiazepoxide), antidiarrheal (diphenoxylate), antiemetic 
(trimethobenzamide), antihypertensive (guanadrel, guaneth-
idine), antipsychotic (perphenazine-amitriptyline), diuretic 
(ethacrynic acid), hormonal (dessicated thyroid), laxative 
(mineral oil), niacin, sedative (meprobamate, quazepam, 
halazepam, chlorazepam), stimulants (amphetamine and 
anorexics, methylphenidate) and vasodilatory (isoxsuprine, 
nylidin). 
  Iron supplements were categorized into group 3. For the 
treatment of anemia, a daily dose of less than 325 mg per day 
is recommended, due to the risk of constipation. NSAIDs 
with a high risk of central nervous system side effects, gas-
trointestinal ulcer bleeding, renal failure, high blood pressure 
and heart failure are included in group 1. Acetaminophen, 
for minor pain relief, or other NSAIDs, with fewer side ef-
fects, are recommended for a minimum period as substitute 
drugs. For chronic pain, such as arthritis, COX-2 inhibitors 
are recommended for patients that do not have any risks for 
cardiovascular events, such as myocardial infarction. Nar-
cotic analgesics, meperidine and pentazocin are categorized 
into the group 1, and are also included in the Beers, Canadi-
an, and Zhan criteria. Due to adverse side effects of these an-
algesics, including confusion and hallucination, the risk that 
these may occur among patients with delirium or dementia 
would have increased. For severe pain relief, other narcotic 
analgesics such as codeine, morphine or hydromorphine are 
recommended. Aspirin and clopidogrel are relatively safe an-
ticoagulants to use for the elderly. Ticlopidine is categorized 
into group 1, due to its side effect on inducing myelosuppres-
sion. Anticholinergic drugs are categorized into group 1, due 
to the adverse effects of confusion, hallucination, worsening 
dementia, sedation, dry mouth, urinary retention, hydro-
dipsomania and ischuria. Second-generation antihistamine 
drugs are recommended for use instead of antihistamine/
anticholinergic combination drugs. Among antispasmodic 
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group 1. It is recommended to discontinue use of anticholin-
ergic agent medications unless severe gastrodynia is present. 
Oxybutynin, which is rapidly absorbed, is recommended to 
use for only a short period. Antidepressants with strong an-
ticholinergic effects, such as amitriptyline, imipramine and 
doxepin, are categorized into group 1. For substitute drugs, 
TCAs without persistent active metabolites, such as nortryp-
tyline, desipramine and protriptyline or selective serotonin 
reuptake inhibitor (SSRI), or with a short half-life such as 
fluvoxamine, are recommended. Fluoxetine, which has a 
long half-life, is categorized into group 1. Muscle relaxant or 
antispasmodic agents, such as carisoprodol, chlorzoxazone, 
cyclobenzaprine, metaxalone, methocarbamol and orphen-
adrine, also have strong anticholinergic side effects. There-
fore, instead of these, non-pharmacological therapy, medical 
nutrition therapy or physical therapy is recommended. Anti-
hypertensive drugs with central nervous system side effects, 
such as clonidine, methyldopa and reserpine, are categorized 
into group 1 or 2. These medications are rarely used; howev-
er, they are required to be taken into consideration. An alpha 
blocker such as doxazocin, and a short-acting calcium block-
er such as nifedipine, are in high risk that they carry a high 
risk of patient fall due to orthostatic hypotension. Instead, a 
long-acting calcium blocker and a low dose of diuretics are 
recommended for hypertensive drugs. Benzodiazepines are 
less addictive and have fewer side effects than barbiturates 
(group 1), including fewer falls, fractures and CNS side ef-
fects (e.g., stupor). However, diazepam, chlordiazepoxide 
and flurazepam with a long half-life are categorized into 
group 1, due to a high risk of side effects with an increased 
effect of sedation. Instead, benzodiazepines (group 2) with 
a short half-life are recommended. The increased sensitivity 
of drug effects among the elderly requires lower doses; lo-
razepam 3 mg/day, oxazepam 60 mg/day, alprazolam 2 mg/
day, and temazepam 15 mg/day, as needed for a minimum 
period. 
2. Potentially Inappropriate Medical Use in Older Adults 
Considering Diagnoses or Conditions
As shown in Table 3, there were 93 drugs potentially inap-
propriate for the elderly with 29 diagnoses, group 1, group 
2, and group 3 included 63, 28, and 3 drugs, respectively. 
Drugs for anorexia and malnutrition (dextroamphetamine, 
methamphetamine, pemolin) and cognitive impairment 
(dextroamphetamine, methamphetamine, and pemollin) 
were excluded from Beers’s criteria [6] because they were 
not included in the reimbursable drug list in Korea. Chlor-
diazepoxide-amitriptyline, clidinium-chlordiazepoxide, 
quazepam and halazepam needed to be carefully monitored 
for chronic obstructive pulmonary disease (COPD) patients, 
and guaethidine for patients with depression were excluded 
because they are not on the market in Korea. Phenylpropa-
nolamine hydrochloride for hypertension was also removed 
from the US market in 2001 and Beers criteria. On the other 
hand, anorexia and malnutrition (fluoxetin) was removed 
based upon the consensus among the researcher. 
  Among 29 diseases, the clinical importance of syndrome 
of inappropriate secretion of antidiuretic hormone (SI-
ADH)/hyponatremia has not been appreciated. Therefore, 
Citalopram and fluoxepine are categorized into group 3. 
Because TCAs in group 1, including amitryptyline, doxepin, 
imipramine, carry a high risk of arrhythmia due to an in-
crease in electrocardiogram (ECG) QT interval, SSRIs are 
recommended as antidepressants for elderly patients with 
arrhythmia. Anticholinergic drugs, such as oxybutynin and 
tolerodine (which have side effects such as urinary retention) 
antihistamine agents, antispasmodic agents, antidepressants, 
and muscle relaxants are categorized into group 1. Any ad-
verse effects of anticholinergic drugs, muscle relaxants and 
barbiturates on the CNS should be carefully monitored. It 
is recommended to stop the use of methylphenidate (group 
1). With an increase in the prevalence of COPD among the 
elderly, long acting drugs such as diazepam, chlordiazepate 
and chlordiazepoxide with a risk of respiratory inhibition 
are categorized into group 1. Group 1 included the substitute 
drug, propanolol (group 1), which inhibits bronchodilata-
tion. For patients with hypertension, drugs that interact with 
the sympathetic nervous system, such as amphetamines, 
phenylpropanolamine (approval cancelled), pseudoephed-
rine and appetite suppressants, are categorized into group 1. 
For insomnia patients, drugs with stimulatory effects, such 
as amphetamines, methylphenidate, monoamine oxidase 
inhibitor (MAOI), and theophylline are included in group 
1. Since antidopaminergic and anticholinergic agents could 
worsen Parkinson’s disease, it is recommended that meto-
clopramide, gastroprokinetic agents. And tacrine, an anti-
cholinergic agent, be substituted for domperidone and other 
Alzheimer medications, respectively. Trycyclic antidepres-
sants with a risk of orthostatic hypotension and syncope are 
categorized into group 1. For patients with stress-induced 
urinary incontinence, alpha-blockers including doxazocin, 
prazocin and terazocin and TCAs are categorized into group 
1, due to worsening urinary incontinence. 
IV. Discussion
As the aged population grows, the prevalence of chronic de-
generative diseases has increased, along with the number of242 doi: 10.4258/hir.2010.16.4.231 www.e-hir.org
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prescriptions and drug interactions from polypharmacy for 
elderly patients. In other countries, along with the United 
States of America, the criteria for potentially inappropriate 
drugs for elder patients, such as the Beers criteria [6,12] and 
the Canadian criteria [13], have already been proposed for 
use, based on assumption that patients at nursing home will 
use them  for long-term.
  Assuming the current growth rate of aged people, it is pro-
jected to be an aged society by 2018 and a post-aged society 
by 2026. Therefore, it is very important to reconsider the 
quality and effectiveness of pharmaceutical therapy for the 
elderly. For the elderly with frequently prescribed drugs, it is 
crucial to prevent side effects and to improve safety by mini-
mizing inappropriate drug use. Health Insurance Review & 
Assessment Service (HIRA) already has been performing 
quality assessment for medical services since 2001, to guar-
antee the delivery of safe and effective medical services. It 
has been suggested that criteria of drug prescription safety 
for the elderly should be developed for patient safety issues 
[18].
  In this study, the list for inappropriate drugs for elderly was 
determined by using the Delphi evaluation from the expert 
panel, consisting of 7 geriatric specialists, 3 geriatric psy-
chiatrists, a neurologist and 3 clinical pharmacists. The level 
of inappropriateness was determined by taking into account 
the clinical significance of any adverse effects of the drugs 
and the availability of substitute drugs: group 1 lists drugs 
that need to be avoided, group 2 lists drugs that need to be 
monitored, and group 3 lists drugs that have minimal danger 
to the elderly, and thus do not need to be monitored. 
  The expert panel developed a list of 57 potentially inappro-
priate ingredients for the elderly, ID among the 60 ingredi-
ents. Forty-two drugs were classified into group 1, 13 drugs 
into group 2, and 2 drugs into group 3. Ninty-three drugs 
were potentially inappropriate for the elderly with 29 diag-
noses, group 1, 2, and 3 included 63, 28, and 3 drugs, respec-
tively.
  The list should be considered for application in practice 
as follows. First, the list of potentially inappropriate drugs 
was developed with some modification, but complements 
the Beers criteria is focused on a narrow scope of treatment, 
which resulted in the agreement on the adverse effects of the 
drugs in the elderly. However, it is not possible to evaluate 
whether prescription of these drugs is valid for a wider scope 
of treatment [19,20]. In addition, the use of inappropriate 
drugs, which is based on Drug Use Review (DUR) criteria, 
would be more applicable for an outpatient setting, in terms 
of drug-to-drug and drug-to-disease interactions. Studies 
have shown that the Beers criteria fit better for an inpatient 
setting [21,22]. In addition, it has been criticized that there 
are no criteria available to identify false, abusive and over-
lapping prescribing practices, which need to be monitored in 
separate ways. 
  Second, it may not be proper to use substitute drugs for po-
tentially inappropriate drugs. For example, TCAs have been 
on the market for long enough to guarantee their safety in 
some specific situations. For instance, amitriptyline is often 
prescribed for diabetic neuropathy and has been shown to 
be more effective and inexpensive than other drugs [23]. For 
example, TCAs have been widely used for a long time, the 
safety would be guaranteed. Furthermore, substituted drugs 
will be safer and inexpensive. 
  Third, it is difficult to apply monitoring potentially inap-
propriate medication use CD. The patients that have been 
identified to have a disease using the claims data with the 
corresponding disease code might be lower than what is 
actually prevalent. For instance, in order to select a patient 
with asthma, hypertension, and depression, more than one 
claim with the disease code and prescribed drugs must be 
used [24].
  Finally, it is important to keep in mind that the criteria 
for potentially inappropriate drugs for the elderly are only 
a screening tool. In special cases, it would not be proper to 
apply these criteria. For example, it would be appropriate to 
take amitriptyline when the patient needs strong anticholin-
ergic drugs to treat a major depressive disorder and Parkin-
sonism [11]. Hence, for an effective use of criteria, the se-
verity and symptoms of the disease should be accompanied 
in administrative data. In other words, the administration 
of drugs should be approved with supplementary patient 
information for unavoidable circumstances. In addition, 
research on the outcome of adverse effect for potentially in-
appropriate drug administration for elder patients must be 
performed.
  This study especially aimed to develop the list of potentially 
inappropriate drugs for elderly patients using the Delphi 
evaluation from the expert panel, consisting of seven geriat-
ric specialists, three geriatric psychiatrists, a neurologist and 
three clinical pharmacists. This list was extracted from Beers 
criteria, Zahn's classification, and Canadian criteria. Beers 
criteria, developed by literature review and 12 panelists' 
consensus using modified Delphi method, identified 48 indi-
vidual medications or classes of medication to avoid in older 
adults and their potential concerns and 20 disease/condi-
tions and medication to be avoided in older adults with these 
conditions. Zhan's classification was restricted to a subset 
of 33 drugs from the Beers criteria because Medical Expen-
diture Survey (MEPS) does not include sufficient detail on 251 Vol. 16  •  No. 4  •  December 2010 www.e-hir.org
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drug dosage, frequency, and duration of administration. 
Canadian criteria was developed by 32-member national 
panel's consensus and was consisted of list of 71 practices in 
prescribing for elderly people.
  It is expected that the list of inappropriate prescribing for 
the elderly people would be regularly checked if it is to be 
helpful to physicians. For existing criteria based on litera-
ture review and many drugs prescribed for elderly people, 
there is a dearth of evidence-based guidelines, so we relied 
on a consensus panel without own literature review. We did 
not perform surveys on medical record to search for acute 
admission due to adverse drug event because this list will be 
applied to pattern analysis using administrative data.
  Despite these limitations, the Beer criteria have been widely 
utilized for screening in community settings. Willcox et al. 
[25] and Zhan et al. [15] used NMES or MEPS data to in-
vestigate the prescription rate of inappropriate drugs for the 
elderly. Allard et al. [26] investigated the prescription rate 
of inappropriate drugs by the physicians practicing in Sher-
brooke, Quebec, Canada. Fillenbaum et al. [22] and Blalock 
et al. [27] also investigated the prescription rate among the 
elderly in community settings.
  In conclusion, the criteria can be used to improve the qual-
ity of pharmaceutical therapy and the list of potentially inap-
propriate drugs should be used with caution. Further efforts 
are needed to revise periodically a list of inappropriate drugs 
for the elderly reflecting the concurrent medical care. Our 
study focuses on developing list of inappropriate medication 
for the elderly patients. Further studies are needed to assess 
the problems of inappropriate drugs in elderly patients and 
understand factors affecting use of the inappropropriate 
drugs. Moreover, further challenges to  assess hospitalization 
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